The American College of Surgeons Health Policy Research Institute

American College of Surgeons Health Policy Research Institute
Advancing Health Policy Information
for Surgery in the United States

What the Current FDA Drug Shortage Database Shows

Drug shortages · live verification

FDA’s Drug Shortage Database distinguishes current and resolved shortages and discontinuations. A publishable status update must name one exact product record and retrieval time; this guide does not invent a product or national shortage.

Evidence requirement: verify the exact product record and retrieval time before making a current-status claim.Framework source retrieved August 27, 2026

What the current federal page establishes

FDA says shortages can result from manufacturing and quality problems, delays and discontinuations. Manufacturers provide the agency most shortage information, and FDA works with them to prevent or reduce supply disruption. The federal page links to current and resolved shortage records and discontinuations.

That establishes the database’s role, not a shortage for an unnamed medicine. A newsroom update becomes factual only when a specific live record is opened and its product, formulation, status, reason and availability notes are captured.

Record these fields at publication

  1. Generic name and exact product presentation
  2. Database status exactly as displayed
  3. Company or presentation-specific availability notes
  4. Reason or issue stated in the record
  5. FDA update date and newsroom retrieval timestamp
  6. Any FDA-linked extended-use-date information, kept separate from routine labeling
National status is not local inventory

A database record cannot promise that a pharmacy or hospital has stock. Conversely, one local stock problem does not prove that FDA lists a national shortage.

Who may be affected

The product record may matter to manufacturers, wholesalers, pharmacies, hospitals and clinicians planning supply. For patients, the useful newsroom function is to identify the exact federal record and encourage verification with the dispensing pharmacy and treating clinician.

The article must not suggest a substitute, advise a dose change or direct a reader to interrupt treatment. Alternative-product decisions depend on clinical and operational facts outside a shortage database.

What remains uncertain

Even a current federal record may not reveal inventory at a specific location, shipment timing, a hospital’s conservation policy or which patients can receive available supply. A status can also change after retrieval. The story therefore needs a visible “checked at” time and a scheduled recheck immediately before publication.

When shortages affect operating-room medicines or supplies, workforce and facility capability still require separate evidence. See the Surgical Workforce and Care Access hub for that distinction.

Primary source framework

U.S. Food and Drug Administration, Drug Shortages. Federal overview retrieved August 27, 2026. Mandatory refresh: add and recheck the exact live database record before publication.

Scroll to Top